Novel technology for the diagnosis and monitoring
of iron toxicity, iron overload, in body fluids
News and Events
Recently published:
- Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Read more…
- The Extent of Labile Plasma Iron (LPI) Predicts for Non-Relapse-Mortality (NRM) in AML and MDS Patients with Systemic Iron Overload Undergoing Allogenic Stem Cell Transplantation Results of the Prospective Read more…
The Technology
Thalassemia, Hereditary Hemochromatosis and other health conditions associated with deranged metabolism or handling of iron often result in the development of acute and/or chronic Iron Overload...
Read more…